Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Local Immunomodulatory Strategies to Prevent Allo‐Rejection in Transplantation of Insulin‐Producing Cells

Advanced Science(2021)10.1002/advs.202003708Source: DataRank Database

Local Immunomodulatory Strategies to Prevent Allo‐Rejection in Transplantation of Insulin‐Producing Cells is a research paper published in Advanced Science (2021). On theSindex it has a DataRank of 0. It has been cited 57 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access57 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 8.30)OA: goldTopics (40)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Natalie K. Brown ORCID,Bo Wang ORCID,Kaavian Shariati ORCID,Kai Wang ORCID,Stephanie Fuchs ORCID

Live enrichment

PubMed:34258870 PMC:PMC8425879 OpenAlex:https://openalex.org/W3180781710

National Institutes of Health

Grant: 1R01DK105967‐01A1

Juvenile Diabetes Research Foundation International

Grant: 2‐SRA‐2018‐472‐S‐B

NIH HHS

Grant: 1R01DK105967-01A1

Engineering an Islet Thread from zwitterionically modified alginates for type 1 diabetes

NHLBI NIH HHS

Grant: R01 HL128452

Juvenile Diabetes Research Foundation International

Grant: 2-SRA-2018-472-S-B

NIDDK NIH HHS

Grant: R01 DK105967

NHLBI NIH HHS

Grant: R01 HL152133

Hartwell Foundation

Novo Nordisk

Hartwell Foundation

FWCI

8.30

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1002/advs.202003708

publisherhttps://doi.org/10.1002/advs.202003708

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202003708

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/advs.202003708

publisherhttps://advanced.onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202003708

Fields of Study

Pancreatic function and diabetesDiabetes Management and Research0301 basic medicine03 medical and health sciencesDiabetes Mellitus, Type 1Graft RejectionHumansImmunomodulationInsulin-Secreting CellsIslets of Langerhans Transplantation

MeSH Terms

Diabetes Mellitus, Type 1Graft RejectionHumansIslets of Langerhans TransplantationInsulin-Secreting CellsImmunomodulation

Keywords

ImmunosuppressionTransplantationMedicineCell therapyIsletImmunologyStem cellInsulinBiologyCell biologySurgeryInternal medicineImmunomodulationtype 1 diabetesBiomaterialsDrug DeliveryGraft RejectionScienceQIslets of Langerhans TransplantationReviewsDiabetes Mellitus, Type 1Insulin-Secreting CellsHumans

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being